mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.4 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |